Skip to main content
DRUG logo

Bright Minds Biosciences Inc.

DRUGNASDAQHealthcareBiotechnology

$55.32Today:- (-)1Y −14.38%

As of Oct 28, 2026 close

Market cap
$543.82M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$47.23$123.75
Volume (live)
-
Avg. volume (3M)
135.74K

Bright Minds Biosciences (DRUG) Income Statement

In fiscal 2025 (fiscal year ended Sep 30, 2025), Bright Minds Biosciences posted a net loss of CAD 12.23M, compared with a net loss of CAD 2.80M a year earlier.

Bright Minds Biosciences Income Statement Analysis

Values in millions CAD

Scroll to see more
Bright Minds Biosciences Inc. income statement - Annual data in millions CAD
BreakdownFY 2025FY 2024FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Period endingSep 2025Dec 2024Sep 2024Sep 2023Sep 2022Sep 2021Sep 2020Sep 2019
Revenue & Gross Profit
Revenue0.000.00-0.000.000.000.000.00
Cost of Revenue0.000.00-0.000.000.000.000.00
Gross Profit0.000.00-0.000.000.000.000.00
Operating Expenses
Research & Development11.081.181.185.0012.186.310.350.13
Selling, General & Administrative2.571.451.452.202.552.310.120.11
Operating Expenses13.942.822.827.3914.988.620.470.24
Operating Income-13.94-2.82-2.82-7.39-14.98-8.62-0.47-0.24
Other Income/Expense
Interest Income1.520.030.030.000.000.000.000.00
Interest Expense0.000.00-0.000.000.000.000.00
Other Income/Expense1.710.02-0.010.010.01-0.18-0.010.00
Income
Income Before Tax-12.23-2.80-2.80-7.37-14.96-8.65-0.48-0.24
Income Tax Expense0.000.00-0.000.000.000.000.00
Net Income-12.23-2.80-2.80-7.37-14.96-8.65-0.48-0.24
Net Income - Continuous Operations-12.23-2.80-2.80-7.37-14.96-8.65-0.48-0.24
Net Income - Discontinued Operations--------
EBITDA-12.15-2.73-2.75-7.30-14.96-0.030.000.00
EBIT-13.61--2.82-7.39-14.73-8.62--
Depreciation & Amortization0.080.070.070.070.018.620.470.24
Earnings Per Share
Basic EPS-2.00-1.00-1.00-2.00-6.00-5.00--
Diluted EPS-2.00-1.00-1.00-2.00-6.00-5.00--
Basic Shares Outstanding6.884.314.313.722.471.791.281.28
Diluted Shares Outstanding6.884.314.313.722.471.791.281.28

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Bright Minds Biosciences Financial Statements

Is Bright Minds Biosciences profitable?

No. Bright Minds Biosciences reported a net loss of CAD 12.23M in fiscal 2025. In fiscal 2024 it lost CAD 2.80M.

What is net profit margin?

Net profit margin is net income divided by revenue. It shows how much of each dollar of sales a company keeps as profit after all costs, interest and taxes. Full definition